Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Millikan · SciRah

Researcher profile · Semantic Scholar

R. Millikan

Share profile

R. Millikan — researcher profile on SciRah

h-index: 46
Works: 127
Citations: 7,600

Most-cited papers

Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
C. Papandreou, D. Daliani, D. Nix, Hong Yang +14 more
2004Journal of Clinical Oncology462 citations Open access
Semantic Scholar
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
A. Aparicio, A. Harzstark, P. Corn, S. Wen +13 more
2013Clinical Cancer Research433 citations Open access
Semantic Scholar
Focus on bladder cancer.
C. Dinney, D. J. McConkey, R. Millikan, Xi-Feng Wu +9 more
2004Cancer Cell314 citations Open access
Semantic Scholar
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
A. Siefker-Radtke, J. Gee, Yu Shen, S. Wen +3 more
2003Journal of Urology305 citations
Semantic Scholar
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
D. McConkey, Woonyoung Choi, Yu Shen, I. Lee +8 more
2015European Urology280 citations Open access
Semantic Scholar
Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
Xi-Feng Wu, Jian Gu, H. Grossman, Christopher I. Amos +7 more
2006American Journal of Human Genetics271 citations Open access
Semantic Scholar
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.
A. Siefker-Radtke, C. Dinney, N. Abrahams, C. Moran +5 more
2004Journal of Urology266 citations
Semantic Scholar
Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma
S. Matin, V. Margulis, A. Kamat, C. Wood +5 more
2010Cancer227 citations
Semantic Scholar
Dose‐Finding with Two Agents in Phase I Oncology Trials
P. Thall, R. Millikan, Peter R. Mueller, Sang-Joon Lee
2003Biometrics213 citations
Semantic Scholar
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
C. Sternberg, S. Donat, J. Bellmunt, R. Millikan +6 more
2007Urology210 citations
Semantic Scholar
The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.
A. Kamat, J. Gee, C. Dinney, H. B. Grossman +5 more
2006Journal of Urology209 citations
Semantic Scholar
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
E. Jonasch, C. Wood, S. Matin, S. Tu +9 more
2009Journal of Clinical Oncology188 citations Open access
Semantic Scholar
Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center
S. Lynch, Yu Shen, A. Kamat, H. Grossman +4 more
2012European Urology187 citations Open access
Semantic Scholar
Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
Stephen H. Culp, R. Dickstein, H. Grossman, S. Pretzsch +11 more
2013Journal of Urology173 citations Open access
Semantic Scholar
Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.
D. Leibovici, H. Grossman, C. Dinney, R. Millikan +5 more
2005Journal of Clinical Oncology172 citations
Semantic Scholar
Plasmacytoid Urothelial Carcinomas – A Chemo-sensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis
F. Dayyani, B. Czerniak, K. Sircar, M. Munsell +3 more
2012Journal of Urology170 citations Open access
Semantic Scholar
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
A. Siefker-Radtke, A. Kamat, H. B. Grossman, Dallas L. Williams +4 more
2009Journal of Clinical Oncology159 citations Open access
Semantic Scholar
Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience.
A. Siefker-Radtke, G. Walsh, L. Pisters, Yu Shen +3 more
2004Journal of Urology154 citations
Semantic Scholar
Prostate cancer progression in the presence of undetectable or low serum prostate‐specific antigen level
D. Leibovici, P. Spiess, P. Agarwal, S. Tu +4 more
2007Cancer129 citations Open access
Semantic Scholar
Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer
Lu Wang, A. Rotnitzky, Xi-Hong Lin, R. Millikan +1 more
2012Journal of the American Statistical Association109 citations Open access
Semantic Scholar
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
P. Sweeney, R. Millikan, M. Donat, Christopher G. Wood +6 more
2003Journal of Urology109 citations
Semantic Scholar
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.
R. Millikan, S. Wen, L. Pagliaro, Melissa A. Brown +3 more
2008Journal of Clinical Oncology94 citations Open access
Semantic Scholar
Bayesian and frequentist two‐stage treatment strategies based on sequential failure times subject to interval censoring
P. Thall, L. Wooten, Christopher J. Logothetis, R. Millikan +1 more
2007Statistics in Medicine86 citations
Semantic Scholar
The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.
A. Kamat, T. Karashima, D. Davis, L. Lashinger +5 more
2004Molecular Cancer Therapeutics86 citations
Semantic Scholar
Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells
A. Papageorgiou, L. Lashinger, R. Millikan, H. B. Grossman +3 more
2004Cancer Research84 citations
Semantic Scholar
Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.
J. Slaton, R. Millikan, K. Inoue, T. Karashima +5 more
2004Journal of Urology83 citations
Semantic Scholar
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.
A. Siefker-Radtke, R. Millikan, S. Tu, D. Moore +3 more
2002Journal of Clinical Oncology82 citations
Semantic Scholar
A Phase II Clinical Trial of Sequential Neoadjuvant Chemotherapy with Ifosfamide, Doxorubicin, and Gemcitabine, followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results
A. Siefker-Radtke, C. Dinney, Yu Shen, Dallas L. Williams +3 more
2012Cancer71 citations Open access
Semantic Scholar
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
P. Thall, C. Logothetis, L. Pagliaro, S. Wen +3 more
2007Journal of the National Cancer Institute65 citations Open access
Semantic Scholar
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
L. Pagliaro, R. Millikan, S. Tu, Dallas L. Williams +3 more
2002Journal of Clinical Oncology60 citations
Semantic Scholar
Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience
Alan J. Rodney, N. Tannir, A. Siefker-Radtke, Ping Liu +5 more
2010Urologic oncology54 citations Open access
Semantic Scholar
The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
R. Svatek, S. Shariat, Robert E. Lasky, E. Skinner +15 more
2010Clinical Cancer Research53 citations Open access
Semantic Scholar
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers.
A. Siefker-Radtke, Xin-Qiao Zhang, Charles C. Guo, Yu Shen +8 more
2016Molecular Therapy52 citations Open access
Semantic Scholar
Targeting the Interleukin-11 Receptor α in Metastatic Prostate Cancer: A First-in-man Study
R. Pasqualini, R. Millikan, Dawn R. Christianson, M. Cardó-Vila +16 more
2015Cancer51 citations Open access
Semantic Scholar
mTOR inhibitor associated noninfectious pneumonitis in patients with renal cell cancer: management, predictors, and outcomes
B. Atkinson, Diana H. Cauley, C. Ng, R. Millikan +4 more
2013BJU International50 citations Open access
Semantic Scholar
A Phase I/II study of strontium‐89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases
L. Pagliaro, E. Delpassand, Dallas L. Williams, R. Millikan +2 more
2003Cancer40 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy with DD-MVAC and bevacizumab in high-risk urothelial cancer: Results from a phase II trial at the M. D. Anderson Cancer Center.
A. Siefker-Radtke, A. Kamat, P. Corn, S. Matin +3 more
2012Journal of Clinical Oncology39 citations
Semantic Scholar
Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer.
R. Millikan, P. Thall, Sang-Joon Lee, Donnah M. Jones +4 more
2003Journal of Clinical Oncology38 citations
Semantic Scholar
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after progression during treatment with other targeted therapies
M. Matrana, C. Duran, A. Shetty, Lianchun Xiao +7 more
2013European Journal of Cancer34 citations Open access
Semantic Scholar
Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival.
A. Montero, C. Diaz-Montero, R. Millikan, Jun Liu +6 more
2009Annals of Oncology31 citations Open access
Semantic Scholar
Randomized, adaptive, phase II selection trial of four chemotherapy regimens in androgen independent prostate cancer (AIPC).
R. Millikan, P. Thall, L. Pagliaro, Dallas L. Williams +2 more
2004Journal of Clinical Oncology31 citations
Semantic Scholar
Neoadjuvant chemotherapy with DD-MVAC and bevacizumab in high-risk urothelial cancer: Results from a phase II trial at the M. D. Anderson Cancer Center.
A. Siefker-Radtke, A. Kamat, P. Corn, S. Matin +3 more
2012Journal of Clinical Oncology28 citations
Semantic Scholar
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
F. Dayyani, A. Zurita, G. Nogueras-González, R. Slack +5 more
2016BMC Cancer15 citations Open access
Semantic Scholar
Reply from authors re
N. Tannir, P. Thall, R. Millikan
201215 citations
Semantic Scholar
Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinoma
M. Campbell, R. Millikan, E. Altınmakas, Lianchun Xiao +5 more
2014Clinical Genitourinary Cancer9 citations Open access
Semantic Scholar
Uncommon Cancers of the Bladder
A. Siefker-Radtke, B. Czerniak, C. Dinney, R. Millikan
20069 citations
Semantic Scholar
Neoadjuvant chemotherapy with DD-MVAC and bevacizumab in high-risk urothelial cancer: Results from a phase II trial at the University of Texas M. D. Anderson Cancer Center.
A. Siefker-Radtke, A. Kamat, P. Corn, S. Matin +3 more
20128 citations
Semantic Scholar
Chemotherapy for advanced prostate cancer: 25 years later.
C. Logothetis, R. Millikan
2008Journal of Clinical Oncology8 citations
Semantic Scholar
1521: Variant Histology in Bladder Cancer - Experience in 1246 Patients Undergoing Cystectomy
P. Black, W. Kassouf, G. Brown, A. Kamat +6 more
20078 citations
Semantic Scholar
A phase II trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine (IAG), followed by cisplatin, gemcitabine and ifosfamide (CGI) in locally advanced urothelial cancer (UC): Final results from the M.D. Anderson Cancer Center
A. Siefker-Radtke, R. Millikan, A. Kamat, Yu Shen +3 more
20086 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Siefker-Radtke×22
Invite
A. Siefker-Radtke — researcher profile on SciRah
C. Dinney×12
Invite
C. Dinney — researcher profile on SciRah
C. Logothetis×11
Invite
C. Logothetis — researcher profile on SciRah
C. Dinney×11
Invite
C. Dinney — researcher profile on SciRah

×10

Invite

P. Corn — researcher profile on SciRah

Invite

A. Kamat — researcher profile on SciRah

Invite

N. Tannir — researcher profile on SciRah

Invite

Yu Shen — researcher profile on SciRah

Invite

S. Tu — researcher profile on SciRah

Invite

P. Thall — researcher profile on SciRah

Invite

H. Grossman — researcher profile on SciRah

Dallas L. Williams×8

Invite

Dallas L. Williams — researcher profile on SciRah